McMaster University

McMaster University

Faculty of
Health Sciences

Announcement — Chair, Department of Biochemistry and Biomedical Sciences

Gerard (Gerry) D. Wright

Gerard (Gerry) D. Wright, B.Sc., Ph.D.

Dated: June 16, 2006

From: John G. Kelton, MD, Dean and Vice-President, Faculty of Health Sciences

It is my pleasure to announce the reappointment of Dr. Gerry Wright as Chair, Department of Biochemistry and Biomedical Sciences at McMaster University for a second term effective July 1, 2006. He will be on administrative leave until January 1, 2007 and Eric Brown will be acting chair.

Gerry Wright is a professor in the Department of Biochemistry and Biomedical Sciences and an associate member of the Department of Chemistry.  He has been the chair of the Department of Biochemistry and Biomedical Sciences since 2001 and is the founding director of the McMaster Antimicrobial Research Centre.  He received his B.Sc. in Biochemistry (1986) and his Ph.D. in Chemistry (1990) from the University of Waterloo.  He followed this up with 2 years of post doctoral research at Harvard Medical School in Boston and joined the Department of Biochemistry at McMaster in 1993.  He holds a Canada Research Chair in Antibiotic Biochemistry and has received Canadian Institutes of Health Research Scientist (2000-2005) and Medical Research Council of Canada Scholar (1995-2000), Premiers' Research Excellence (1999) and Polanyi Prize (1993) awards.  He is the director of the American Chemical Society Short Course on Antibiotics and Antibacterial Agents.  Dr. Wright is co-founder, with Dr. Eric Brown, of the McMaster High Throughput Screening Facility.  He is a member of the editorial boards of the scientific peer-reviewed journals Chemistry and Biology and the Journal of Antibiotics.

Dr. Wright's laboratory conducts research on the chemical biology of antibiotic resistance including resistance to aminoglycoside, glycopeptide and streptogramin families of antibiotics, on the mechanisms of antibiotic biosynthesis, and on the discovery of new antimicrobial targets, in particular antifungal agents.  He is the author of over 100 published papers and book chapters.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0